Cambridge neighbors, NIBR and Harvard, further disrupt technology. Read how their alliance is accelerating drug discovery.

A conversation with Novartis Chief Digital Officer Bertrand Bodson

New head of oncology research hopes to build on recent advances, explore new therapeutic approaches and beat certain cancers for good.

By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs

Experts call for significant changes to facilitate the discovery of new treatments.